# Blackstone Secured Lending Fund: overview BXSL · NYSE · CIK 1736035 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bxsl.md) · [Financials](/companies/bxsl/financials.md) · [Filings](/companies/bxsl/filings.md) · [Insiders](/companies/bxsl/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.75](/filings/0001736035-25-000021.md) | not reported | [0.66](/filings/0001736035-26-000010.md) | [0.68](/filings/0001736035-26-000016.md) | [0.57](/filings/0001736035-25-000021.md) | not reported | [0.11](/filings/0001736035-26-000010.md) | [0.04](/filings/0001736035-26-000016.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [3.19](/filings/0001736035-24-000006.md) | [2.44](/filings/0001736035-25-000008.md) | [3.65](/filings/0001736035-26-000004.md) | [3.45](/filings/0001736035-26-000004.md) | [2.46](/filings/0001736035-26-000004.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bxsl/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $150.8m | 6,358,639 | | Added +360,669 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $133.6m | 5,633,953 | | Reduced −124,457 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $121.5m | 5,126,083 | | Added +397,788 | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $98.7m | 4,161,539 | | Added +2,041,061 | | [STRS OHIO](/funds/820478.md) | 2026-06-30 | $94.8m | 4,000,000 | | Unchanged | | [Ensign Peak Advisors, Inc](/funds/1454984.md) | 2026-06-30 | $78.1m | 3,295,115 | | Added +693,000 | | [Blackstone Inc.](/funds/1393818.md) | 2026-06-30 | $76.0m | 3,206,530 | | Unchanged | | [NOMURA ASSET MANAGEMENT CO LTD](/funds/1055964.md) | 2026-06-30 | $74.8m | 3,154,452 | | Reduced −407,457 | | [Generali Asset Management SPA SGR](/funds/2046751.md) | 2026-06-30 | $61.7m | 2,602,594 | | Added +83,114 | | [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $54.0m | 2,276,137 | | Reduced −249,563 | ## Recent filings [All 316 filings](/companies/bxsl/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-30 | 17:00 ET | [8-K](/filings/0001213900-26-105305.md) | 5.07 Shareholder vote results | 0001213900-26-105305 | | 2026-08-12 | 16:17 ET | [8-K](/filings/0001213900-26-088376.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-088376 | | 2026-08-06 | 06:43 ET | [8-K](/filings/0001213900-26-085889.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-085889 | | 2026-08-06 | 06:13 ET | [10-Q](/filings/0001736035-26-000016.md) | Quarterly report, period 2026-06-30 | 0001736035-26-000016 | | 2026-07-24 | 16:31 ET | [8-K](/filings/0001213900-26-081414.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-081414 | | 2026-06-29 | 16:05 ET | [DEF 14A](/filings/0001193125-26-288415.md) | Proxy statement, period 2026-09-24 | 0001193125-26-288415 | | 2026-06-18 | 16:05 ET | [8-K](/filings/0001213900-26-070092.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-070092 | | 2026-05-21 | 16:08 ET | [8-K](/filings/0001213900-26-060043.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-060043 | | 2026-05-07 | 06:24 ET | [8-K](/filings/0001213900-26-053022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-053022 | | 2026-05-07 | 06:13 ET | [10-Q](/filings/0001736035-26-000010.md) | Quarterly report, period 2026-03-31 | 0001736035-26-000010 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001736035-26-000004.md), filed Feb 25, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1736035 - Tickers: BXSL - Exchange: NYSE - SIC code: not reported - State of incorporation: DE - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.